Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.

Dr. Thomas Roger Sawyer M.B.A., Ph.D.

Chief Financial Officer, Company Secretary & Director

Mr. Desmond M. Balakrishnan B.A., L.L.B.

Όνομα	Τίτλος
Dr. Thomas Roger Sawyer M.B.A., Ph.D.	Chief Financial Officer, Company Secretary & Director
Mr. Desmond M. Balakrishnan B.A., L.L.B.	Legal Counsel & Director
Dr. Sina Habibi	Co-Founder, Chief Executive Officer & Director
Dr. Seyed-Mahdi Khaligh-Razavi	Co-Founder & Chief Information Officer

Cognetivity Neurosciences Ltd.

Cognetivity Neurosciences Ltd. Δομή της διοίκησης

Πληροφορίες για τη διοίκηση